Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study

about

Sitagliptin: A Review in Type 2 Diabetes.Association between dipeptidyl peptidase-4 inhibitor drugs and risk of acute pancreatitis: A meta-analysis.Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study.

P2860

Q39081543-439D02BD-2D05-4814-9D77-52C683B056BC Q47196605-CFD16707-910C-4FFF-B6C9-91236D7D4DB1 Q55086466-AD7E6408-6376-46B8-8A79-4DFD3A56FE79

P2860

Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study

Item

http://www.wikidata.org/entity/Q37206067

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dipeptidyl Peptidase-4 Inhibit ...... nts: A Nationwide Cohort Study

@en

Dipeptidyl Peptidase-4 Inhibit ...... ts: A Nationwide Cohort Study.

@nl

type

Item

label

Dipeptidyl Peptidase-4 Inhibit ...... nts: A Nationwide Cohort Study

@en

Dipeptidyl Peptidase-4 Inhibit ...... ts: A Nationwide Cohort Study.

@nl

prefLabel

Dipeptidyl Peptidase-4 Inhibit ...... nts: A Nationwide Cohort Study

@en

Dipeptidyl Peptidase-4 Inhibit ...... ts: A Nationwide Cohort Study.

@nl

P1476

Dipeptidyl Peptidase-4 Inhibit ...... nts: A Nationwide Cohort Study

@en

P2093

Jou-Wei Lin

http://www.w3.org/2001/XMLSchema#string

Mei-Shu Lai

http://www.w3.org/2001/XMLSchema#string

Shu-Ting Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies

Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin

Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Standards of medical care in diabetes--2014

Pancreatic safety of incretin-based drugs--FDA and EMA assessment

Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.

Calcium release channel RyR2 regulates insulin release and glucose homeostasis

Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study.

P304

e2603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000002603

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yi-Cheng Chang

Chia-Hsuin Chang

Lee-Ming Chuang

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26886601

http://www.w3.org/2001/XMLSchema#string

P932

4998601

http://www.w3.org/2001/XMLSchema#string

Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study

about

P2860

P2860

Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932